Sandra Jernström

High-Throughput 3D Screening Reveals Differences in Drug Sensitivities between Culture Models of JIMT1 Breast Cancer Cells

Vesa Hongisto, Sandra Jernström, Vidal Fey et al. · PLoS ONE · 2013 · 180 citations · Full text

Tissue Engineering, Breast Oncology, Engineering +24

Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes

Tonje H. Haukaas, Leslie R. Euceda, Guro F. Giskeødegård et al. · Cancer & Metabolism · 2016 · 77 citations · Full text

Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer

Miriam R. R. Aure, Sandra Jernström, Marit Krohn et al. · Genome Medicine · 2015 · 38 citations · Full text

Functional Genomics, Engineering, Medicine +15

Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF

Mari Tinholt, Hans Kristian Moen Vollan, Kristine Kleivi Sahlberg et al. · Breast Cancer Research · 2015 · 35 citations · Full text

Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response

Sandra Jernström, Vesa Hongisto, Suvi‐Katri Leivonen et al. · Breast Cancer Targets and Therapy · 2017 · 31 citations · Full text